Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma
暂无分享,去创建一个
Se Hwan Oh | So Hun Kim | Y. S. Kim | M. Nam | S. Hong | Chei Won Kim | S. Hong | Jung Jin Lee | Joohwan Han
[1] H. Kwon,et al. The effects of thyrotropin-suppressing therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. , 2015, Bone.
[2] J. Brito,et al. Is there really an increased incidence of thyroid cancer? , 2014, Current opinion in endocrinology, diabetes, and obesity.
[3] Jung Soo Lim,et al. Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer , 2014, Annals of surgical treatment and research.
[4] V. De Sanctis,et al. Hypoparathyroidism: from diagnosis to treatment , 2012, Current opinion in endocrinology, diabetes, and obesity.
[5] Herb Chen,et al. Parathyroid hormone deficiency after total thyroidectomy: incidence and time. , 2010, The Journal of surgical research.
[6] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[7] S. O'Donnell,et al. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. , 2008, The American journal of clinical nutrition.
[8] B. Larijani,et al. Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference , 2007, Theoretical Biology and Medical Modelling.
[9] J. Romijn,et al. The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.
[10] J. Papadakis,et al. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L‐thyroxine suppressive therapy , 2006, Current medical research and opinion.
[11] N. Alonso,et al. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. , 2005, Endocrine-related cancer.
[12] P. Geusens,et al. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma. , 2005, European journal of endocrinology.
[13] B. Larijani,et al. Effects of levothyroxine suppressive therapy on bone mineral density in premenopausal women , 2004, Journal of clinical pharmacy and therapeutics.
[14] A. Kong,et al. Increased bone mineral density in patients with chronic hypoparathyroidism. , 2003, The Journal of clinical endocrinology and metabolism.
[15] M. Campos,et al. Bone mineral density in hypoparathyroid women on LT4 suppressive therapy. Effect of calcium and 1,25(OH)2 vitamin D3 treatment. , 2003, Journal of musculoskeletal & neuronal interactions.
[16] E. Seeman,et al. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. , 1999, The Journal of clinical endocrinology and metabolism.
[17] B. Uzzan,et al. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. , 1996, The Journal of clinical endocrinology and metabolism.
[18] A. Kung,et al. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. , 1996, The Journal of clinical endocrinology and metabolism.
[19] C. Marcocci,et al. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. , 1994, The Journal of clinical endocrinology and metabolism.
[20] I. Reid,et al. Effect of calcium supplementation on bone loss in postmenopausal women. , 1993, The New England journal of medicine.
[21] F Duboeuf,et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.
[22] B. Dawson-Hughes,et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women , 1991, The New England journal of medicine.
[23] L. Mosekilde,et al. Effects of thyroid hormones on bone and mineral metabolism. , 1990, Endocrinology and metabolism clinics of North America.
[24] M. Lee,et al. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. , 1990, The Journal of clinical endocrinology and metabolism.
[25] G. Martínez,et al. Bone Changes in Pre- and Postmenopausal Women with Thyroid Cancer on Levothyroxine Therapy: Evolution of Axial and Appendicular Bone Mass , 1998, Osteoporosis International.
[26] P. Ladenson,et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. , 1998, Thyroid : official journal of the American Thyroid Association.
[27] M. Haussler,et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. , 1997, The Journal of endocrinology.